Keywords: bayer, factor, viii, drug, gets, fda, go-ahead

Bayer's Factor VIII drug gets FDA go-ahead

Article | 20 October 2008

Print This

Germany's Bayer HealthCare has received an additional indication from the US Food and Drug Administration for its Kogenate FS antihemophilic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in